What Doctors Don't Tell YouErythromycin treatment in infants, particularly those in the first two weeks of life, increases the risk of a gastrointestinal disorder called infantile hypertrophic pyloric stenosis (IHPS).
Erythromycin treatment in infants, particularly those in the first two weeks of life, increases the risk of a gastrointestinal disorder called infantile hypertrophic pyloric stenosis (IHPS).
